Vital Farms (NASDAQ:VITL) PT Raised to $30.00 at Stifel Nicolaus

Vital Farms (NASDAQ:VITL) had its price target increased by research analysts at Stifel Nicolaus from $22.00 to $30.00 in a research note issued on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 12.07% from the company’s current price.

VITL has been the subject of several other research reports. TheStreet upgraded shares of Vital Farms from a “c” rating to a “b-” rating in a research report on Monday, March 18th. Lake Street Capital boosted their price objective on shares of Vital Farms from $26.00 to $32.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, William Blair assumed coverage on shares of Vital Farms in a research report on Wednesday, April 10th. They issued an “outperform” rating on the stock. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, Vital Farms presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.00.

Vital Farms Trading Up 1.2 %

Shares of VITL traded up $0.33 during mid-day trading on Friday, reaching $26.77. The stock had a trading volume of 101,016 shares, compared to its average volume of 405,288. Vital Farms has a 52-week low of $10.00 and a 52-week high of $27.37. The firm has a market cap of $1.12 billion, a price-to-earnings ratio of 46.00 and a beta of 0.89. The business’s fifty day moving average is $21.96 and its 200 day moving average is $16.53. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.00 and a quick ratio of 2.49.

Vital Farms (NASDAQ:VITL) last posted its quarterly earnings data on Thursday, March 7th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.14 by $0.03. Vital Farms had a net margin of 5.42% and a return on equity of 14.22%. The business had revenue of $135.81 million during the quarter, compared to analyst estimates of $131.10 million. During the same quarter last year, the firm posted $0.04 earnings per share. On average, sell-side analysts predict that Vital Farms will post 0.77 EPS for the current fiscal year.

Insiders Place Their Bets

In other Vital Farms news, CEO Russell Diez-Canseco sold 27,528 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $15.49, for a total value of $426,408.72. Following the sale, the chief executive officer now directly owns 223,568 shares of the company’s stock, valued at $3,463,068.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CEO Russell Diez-Canseco sold 27,528 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $15.49, for a total transaction of $426,408.72. Following the transaction, the chief executive officer now directly owns 223,568 shares of the company’s stock, valued at $3,463,068.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Matthew Ohayer sold 100,000 shares of the firm’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $21.38, for a total value of $2,138,000.00. Following the transaction, the chairman now directly owns 7,582,777 shares in the company, valued at $162,119,772.26. The disclosure for this sale can be found here. Insiders have sold 260,125 shares of company stock valued at $5,580,996 over the last three months. Company insiders own 30.20% of the company’s stock.

Hedge Funds Weigh In On Vital Farms

Hedge funds and other institutional investors have recently modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Vital Farms by 52.8% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,196 shares of the company’s stock worth $95,000 after acquiring an additional 2,833 shares during the period. Tower Research Capital LLC TRC lifted its holdings in shares of Vital Farms by 211.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,175 shares of the company’s stock valued at $97,000 after buying an additional 4,192 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Vital Farms during the 3rd quarter valued at about $119,000. DekaBank Deutsche Girozentrale acquired a new stake in shares of Vital Farms during the 4th quarter valued at about $127,000. Finally, New York State Common Retirement Fund lifted its holdings in shares of Vital Farms by 49.0% during the 4th quarter. New York State Common Retirement Fund now owns 10,169 shares of the company’s stock valued at $160,000 after buying an additional 3,346 shares during the last quarter. Institutional investors and hedge funds own 98.59% of the company’s stock.

About Vital Farms

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.